XML 21 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 27, 2019
Mar. 28, 2018
Cash flows from operating activities:    
Net income $ 15,490 $ 9,759
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 6,233 6,514
Operating (gains), losses and other charges, net (8,935) 360
Amortization of deferred financing costs 152 152
Gain on investments 39 0
Gain on early extinguishments of debt and leases (74) 0
Deferred income tax expense 1,476 1,118
Share-based compensation 2,253 1,350
Decrease (increase) in assets:    
Receivables 7,428 1,821
Inventories 121 33
Other current assets 2,904 2,739
Other assets 2,897 (160)
Increase (decrease) in liabilities:    
Accounts payable (1,471) (9,865)
Accrued salaries and vacations (6,439) (4,048)
Accrued taxes (494) 38
Other accrued liabilities (5,918) (5,948)
Other noncurrent liabilities (3,116) (413)
Net cash flows provided by operating activities 12,468 3,450
Cash flows from investing activities:    
Capital expenditures (3,109) (4,148)
Acquisition of restaurants and real estate (4,706) (8,418)
Proceeds from sales of restaurants and real estate 7,914 4
Investment purchases (1,300) 0
Collections on notes receivable 425 859
Issuance of notes receivable (571) (1,934)
Net cash flows used in investing activities (1,347) (13,637)
Cash flows from financing activities:    
Revolver borrowings 28,500 39,500
Revolver payments (31,500) (16,500)
Long-term debt payments (795) (823)
Proceeds from exercise of stock options 107 1,013
Tax withholding on share-based payments (3,178) (1,696)
Purchase of treasury stock (8,089) (15,691)
Net bank overdrafts 705 3,320
Net cash flows (used in) provided by financing activities (14,250) 9,123
Decrease in cash and cash equivalents (3,129) (1,064)
Cash and cash equivalents at beginning of period 5,026 4,983
Cash and cash equivalents at end of period $ 1,897 $ 3,919